Jahanzeb M, Lin HM, Wu Y, Zhang P, et al. Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States. Oncologist 2022 Jul 4. pii: 6628677. doi: 10.1093.
PMID: 35781589